The sterile injectables CDMO market is poised for growth due to the rising demand for biologics, biosimilars, and advanced injectable formats. Opportunities include expansion in large molecule and ...

Undergraduate students recently visited the SMU to aseptically manufacture lipid nanoparticles. Credit: Nathaniel Milton. WEST LAFAYETTE, Ind. — A mobile laboratory that Eli Lilly and Company used to ...

WILMINGTON, Del. & WHIPPANY, N.J.--(BUSINESS WIRE)--The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million ...

WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...

The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...

The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...

WICHITA, Kan., March 17, 2026 /PRNewswire/ -- Fagron Sterile Services (FSS) today announced a major milestone in strengthening the nation's supply of critical injectable medicines, with its Sterile ...

A partnership between a Lee-based provider of sterile injectable medical products and a multinational pharmaceutical packaging company has turned into an acquisition. Berkshire Sterile Manufacturing ...

COSTA MESA, CA, UNITED STATES, March 19, 2026 /EINPresswire.com/ — Pyramid Pharma Services, a U.S.-based contract development and manufacturing organization (CDMO ...